Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study

• Egile Nagusiak: Cascavilla N (Egilea), De Stefano V (Egilea), Pane F (Egilea), Pancrazzi A (Egilea), Iurlo A (Egilea), Gobbi M (Egilea), Palandri F (Egilea), Specchia G (Egilea), Liberati AM (Egilea), D’Adda M (Egilea), Gaidano G (Egilea), Fjerza R (Egilea), Achenbach H (Egilea), Smith J (Egilea), Wilde P (Egilea), Vannucchi AM (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2015-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Nicola Cascavilla,1 Valerio De Stefano,2 Fabrizio Pane,3 Alessandro Pancrazzi,4 Alessandra Iurlo,5 Marco Gobbi,6 Francesca Palandri,7 Giorgina Specchia,8 A Marina Liberati,9 Mariella D’Adda,10 Gianluca Gaidano,11 Rajmonda Fjerza,4 Heinrich Achenbach,12 Jonathan Smith,13 Paul Wilde,13 Aless...